Summary
Verizon Communications Inc. reported solid financial results for the period ending June 29, 2025. Total operating revenues increased by 5.2% to $34.5 billion for the quarter and 3.4% to $68.0 billion for the first six months of the year, driven primarily by strong performance in the Consumer segment. Net income attributable to Verizon also saw a notable increase, reaching $5.0 billion for the quarter and $9.9 billion for the six-month period. The company continues to invest heavily in its network infrastructure, particularly in 5G and fiber, with capital expenditures totaling $8.0 billion for the first half of the year. Management's focus remains on network enhancement, innovative service offerings, customer base growth, and delivering strong financial and operating results.
Financial Highlights
46 data points| Revenue | $34.50B |
| SG&A Expenses | $7.81B |
| Operating Expenses | $26.33B |
| Operating Income | $8.17B |
| Net Income | $5.00B |
| EPS (Basic) | $1.18 |
| EPS (Diluted) | $1.18 |
| Shares Outstanding (Basic) | 4.22B |
| Shares Outstanding (Diluted) | 4.23B |
Key Highlights
- 1Total operating revenues increased by 5.2% to $34.5 billion in Q2 2025 and 3.4% to $68.0 billion for the first six months.
- 2Net income attributable to Verizon increased to $5.0 billion for the quarter and $9.9 billion for the six-month period.
- 3Consumer segment revenue grew by 6.9% year-over-year in the quarter, driven by increases in service and wireless equipment revenue.
- 4Business segment revenue saw a slight decrease of 0.3% in the quarter, impacted by declines in Enterprise and Public Sector, partially offset by growth in Business Markets and Other.
- 5Capital expenditures for the first six months were $8.0 billion, reflecting ongoing investment in network infrastructure.
- 6Free cash flow for the first six months increased by $306 million to $8.8 billion, demonstrating improved operational cash generation.
- 7The company announced an agreement to acquire Frontier Communications Parent, Inc. for $1.0 billion, subject to regulatory approvals.